Healthcare & Medical Devices Global On demand · 24-48h

Global Handheld Ultrasound Imaging Devices Market Strategic Research Report

Global Handheld Ultrasound Imaging Devices Market Strategic …
$3,500 USD
Market Research Reports
Strategic Research Report
Global Handheld Ultrasound Imaging Devices Market
$2.11B2025
6.3%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Wire Handheld Ultrasound Imaging Devices, Wireless Handheld Ultrasound Imaging Devices

By Application: Hospitals, Clinics, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Philips, GE HealthCare, Siemens Healthineers, Canon Medical Systems, FUJIFILM Sonosite, Samsung Medison, MINDRAY, Esaote, Konica Minolta, SuperSonic Imagine, Butterfly Network, Clarius, Exo Iris, EchoNous, Terason, Kiran Medical Systems, Telemed, SonoScape, CHISON, SIUI, EDAN, VINNO, Wisonic, Dawei Medical, Zoncare, Healcerion, BenQ Medical Technology, Aco Healthcare, Leltek

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 169 pages
Market size 2025
$2.11B
Billion USD
Forecast CAGR
6.3%
2025-2032
Forecast 2032
$3.2B
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

نظرة عامة

Scope of the Report

The global Handheld Ultrasound Imaging Devices market size is predicted to grow from US$ 2,107 million in 2025 to US$ 3,195 million in 2032; it is expected to grow at a CAGR of 6.3% from 2026 to 2032.

In 2025, global Handheld Ultrasound Imaging Devices production reached approximately 30,780 k units,with an average global market price of around US$ 70 per unit, and a gross profit margin of approximately 20%-40%. Handheld Ultrasound Imaging Devices are compact medical imaging devices that integrate ultrasound probes, transducers, signal processing modules, batteries, wired or wireless connectivity, imaging software, and mobile display interfaces into a handheld form. These devices provide real-time ultrasound images through smartphones, tablets, dedicated screens, or connected terminals. They are widely used in emergency medicine, intensive care, anesthesia, obstetrics, vascular access, musculoskeletal examination, primary care, rural healthcare, homecare, and telemedicine. Compared with cart-based ultrasound systems, they emphasize portability, rapid deployment, lower space requirements, bedside scanning, and point-of-care diagnostic accessibility. The industrial chain of Handheld Ultrasound Imaging Devices includes upstream ultrasound transducers, piezoelectric materials, probe housings, beamforming chips, signal processors, batteries, cables, wireless modules, charging components, sensors, imaging algorithms, mobile applications, and cloud platforms. The midstream includes handheld device design, miniaturized hardware integration, probe development, image processing, software interface development, AI-assisted imaging, assembly, calibration, testing, clinical validation, quality control, and regulatory certification. Downstream applications include hospitals, emergency departments, intensive care units, clinics, ambulances, community healthcare centers, rural medical institutions, homecare providers, telemedicine platforms, and mobile medical teams. Related services include training, software upgrades, maintenance, probe repair, connectivity support, image optimization, and after-sales technical support.

The market for Handheld Ultrasound Imaging Devices is expanding rapidly as healthcare providers increase adoption of point-of-care ultrasound, bedside imaging, mobile diagnosis, and telemedicine. Demand is supported by emergency departments, intensive care units, anesthesia departments, ambulances, primary care centers, rural clinics, and homecare settings that require fast, portable, and real-time imaging tools. Product innovation is focused on higher image quality, smaller probe design, stable wired or wireless connectivity, longer battery life, AI-assisted interpretation, cloud storage, and integration with smartphones or tablets. Market studies show continued growth in handheld ultrasound, with 2025 estimates varying by product scope and methodology, while broader point-of-care ultrasound demand remains strong. However, image quality consistency, operator training, regulatory approval, data security, and reimbursement uncertainty remain important challenges. Overall, the market is expected to maintain strong growth, driven by portability, digital healthcare development, emergency care demand, and wider clinical acceptance.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Handheld Ultrasound Imaging Devices market?

What factors are driving Handheld Ultrasound Imaging Devices market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Handheld Ultrasound Imaging Devices market opportunities vary by end market size?

How does Handheld Ultrasound Imaging Devices break out by Type, by Application?

This report presents a comprehensive overview of the global Handheld Ultrasound Imaging Devices market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Wire Handheld Ultrasound Imaging Devices
  • Wireless Handheld Ultrasound Imaging Devices

Segment by Applicable Departments

  • Obstetrics and Gynecology
  • Internal Medicine
  • Urology
  • Others

Segment by Application

  • Hospitals
  • Clinics
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Handheld Ultrasound Imaging Devices market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospitals, Clinics, Others evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Handheld Ultrasound Imaging Devices Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6.3%
Regional growth momentum
Market share by segment
Key metrics
Base value
$2.11B
2025
Forecast
$3.2B
2032
CAGR
6.3%
2025–2032
Regions
5
global
Key companies
PhilipsGE HealthCareSiemens HealthineersCanon Medical SystemsFUJIFILM SonositeSamsung MedisonMINDRAYEsaote
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Wire Handheld Ultrasound Imaging DevicesWireless Handheld Ultrasound Imaging Devices
By Application
HospitalsClinicsOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Wire Handheld Ultrasound Imaging Devices
  • 3.1.3 Wireless Handheld Ultrasound Imaging Devices
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospitals
  • 4.1.3 Clinics
  • 4.1.4 Others
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Philips
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 GE HealthCare
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Siemens Healthineers
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Canon Medical Systems
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 FUJIFILM Sonosite
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Samsung Medison
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 MINDRAY
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Esaote
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Konica Minolta
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 SuperSonic Imagine
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Butterfly Network
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Clarius
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Exo Iris
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 EchoNous
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Terason
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Kiran Medical Systems
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Telemed
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 SonoScape
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 CHISON
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 SIUI
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 EDAN
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 VINNO
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
  • 8.23 Wisonic
  • 8.23.1 Company Overview
  • 8.23.2 Key Products & Segments
  • 8.23.3 Financial Performance (2023–2025)
  • 8.23.4 Business Strategy
  • 8.23.5 SWOT Analysis
  • 8.23.6 Strategic Implications (2026–2032)
  • 8.24 Dawei Medical
  • 8.24.1 Company Overview
  • 8.24.2 Key Products & Segments
  • 8.24.3 Financial Performance (2023–2025)
  • 8.24.4 Business Strategy
  • 8.24.5 SWOT Analysis
  • 8.24.6 Strategic Implications (2026–2032)
  • 8.25 Zoncare
  • 8.25.1 Company Overview
  • 8.25.2 Key Products & Segments
  • 8.25.3 Financial Performance (2023–2025)
  • 8.25.4 Business Strategy
  • 8.25.5 SWOT Analysis
  • 8.25.6 Strategic Implications (2026–2032)
  • 8.26 Healcerion
  • 8.26.1 Company Overview
  • 8.26.2 Key Products & Segments
  • 8.26.3 Financial Performance (2023–2025)
  • 8.26.4 Business Strategy
  • 8.26.5 SWOT Analysis
  • 8.26.6 Strategic Implications (2026–2032)
  • 8.27 BenQ Medical Technology
  • 8.27.1 Company Overview
  • 8.27.2 Key Products & Segments
  • 8.27.3 Financial Performance (2023–2025)
  • 8.27.4 Business Strategy
  • 8.27.5 SWOT Analysis
  • 8.27.6 Strategic Implications (2026–2032)
  • 8.28 Aco Healthcare
  • 8.28.1 Company Overview
  • 8.28.2 Key Products & Segments
  • 8.28.3 Financial Performance (2023–2025)
  • 8.28.4 Business Strategy
  • 8.28.5 SWOT Analysis
  • 8.28.6 Strategic Implications (2026–2032)
  • 8.29 Leltek
  • 8.29.1 Company Overview
  • 8.29.2 Key Products & Segments
  • 8.29.3 Financial Performance (2023–2025)
  • 8.29.4 Business Strategy
  • 8.29.5 SWOT Analysis
  • 8.29.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Handheld Ultrasound Imaging Devices market size?
The global Handheld Ultrasound Imaging Devices market is estimated at US$ 2.11 billion in 2025 (base year) and is projected to reach US$ 3.19 billion by 2032.
What growth rate is expected for the Handheld Ultrasound Imaging Devices market through 2032?
The market is expected to grow at a CAGR of 6.3% from 2026 to 2032, expanding from US$ 2.11 billion in 2025 to US$ 3.19 billion in 2032, roughly 1.5 times its base-year value.
How is Handheld Ultrasound Imaging Devices defined?
In 2025, global Handheld Ultrasound Imaging Devices production reached approximately 30,780 k units,with an average global market price of around US$ 70 per unit, and a gross profit margin of approximately 20%-40%. Handheld Ultrasound Imaging Devices are compact medical imaging devices that integrate ultrasound probes, transducers, signal processing modules, batteries, wired or wireless connectivity, imaging software, and mobile display interfaces into a handheld form.
How is the Handheld Ultrasound Imaging Devices market segmented by type?
By type, the market is segmented into Wire Handheld Ultrasound Imaging Devices and Wireless Handheld Ultrasound Imaging Devices.
What are the key applications of Handheld Ultrasound Imaging Devices?
Key applications covered include Hospitals, Clinics and Others.
Which companies are profiled in the Handheld Ultrasound Imaging Devices market report?
Key players profiled include Philips, GE HealthCare, Siemens Healthineers, Canon Medical Systems, FUJIFILM Sonosite, Samsung Medison, MINDRAY and Esaote, among 29 companies covered in total.
What geographies does the Handheld Ultrasound Imaging Devices market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Handheld Ultrasound Imaging Devices?
Demand is supported by emergency departments, intensive care units, anesthesia departments, ambulances, primary care centers, rural clinics, and homecare settings that require fast, portable, and real-time imaging tools.
What are the main risks and barriers in the Handheld Ultrasound Imaging Devices market?
However, image quality consistency, operator training, regulatory approval, data security, and reimbursement uncertainty remain important challenges.
Who should buy the Handheld Ultrasound Imaging Devices market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospitals, Clinics and Others, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Handheld Ultrasound Imaging Devices market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from ‏3,500.00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.